Home Ingredients Salacia (Salacinol)
Metabolic HealthWeight Management

Salacia (Salacinol)

Salacia reticulata / Salacia oblonga / Salacia chinensis
Evidence Level
Moderate
5 Clinical Trials
4 Documented Benefits
3/5 Evidence Score

Ayurvedic plant genus (Kothala himbutu) with α-glucosidase inhibitor activity. Multiple RCTs show reduced postprandial glucose and insulin spikes. Active compounds salacinol and kotalanol mimic acarbose mechanism naturally.

Studied Dose T2D (Kajimoto): 240 mg/day S. reticulata × 6 wk. NR-Salacia: 250-500 mg with carb meal. Heacock 2005: 500-1000 mg S. oblonga. STANDARD: 200-1000 mg with largest carb meal.
Active Compound Salacinol, kotalanol, neokotalanol (thiosugar sulfonium sulfates) — selective α-glucosidase inhibitors

Benefits

Reduced postprandial glucose spikes

Multiple human RCTs across S. reticulata, S. oblonga, and S. chinensis consistently show 14-29% reductions in postprandial glucose AUC after carbohydrate-rich meals when Salacia is co-administered. Williams 2007 (Am J Clin Nutr) showed acute reductions in patients with type 2 diabetes.

Supported by Trial 1, Trial 4

Reduced insulin response

Heacock 2005 (n=39 healthy adults) showed Salacia oblonga extract significantly reduced postprandial insulin response in a dose-dependent manner. Lower insulin demand suggests improved metabolic efficiency on carbohydrate loads.

Supported by Trial 2, Trial 3

HbA1c improvement (T2D)

Kajimoto et al. T2D crossover trial: 240 mg/day S. reticulata for 6 weeks produced significant reductions in fasting plasma glucose, HbA1c, and BMI vs placebo. Effects align with sustained carbohydrate digestion modulation.

Supported by Trial 5, Trial 4

Increased breath hydrogen (mechanism confirmation)

Heacock 2005 documented increased breath hydrogen excretion after Salacia ingestion — confirming carbohydrates are reaching the colon undigested for bacterial fermentation, the same mechanism of action as prescription acarbose.

Supported by Trial 2

Mechanism of action

1

α-Glucosidase inhibition

Salacinol and kotalanol — unique thiosugar sulfonium sulfate compounds — competitively inhibit intestinal brush border α-glucosidase enzymes (sucrase, maltase, isomaltase). This delays the breakdown of disaccharides and oligosaccharides into absorbable monosaccharides, blunting the postprandial glucose surge. Mechanism parallels prescription acarbose.

2

α-Amylase inhibition

Aqueous extracts of S. reticulata also inhibit pancreatic α-amylase activity, slowing the upstream breakdown of starches into oligosaccharides. Combined with α-glucosidase inhibition, this provides 'two-step' carbohydrate digestion modulation.

3

Selective enzyme inhibition (no glucose effect alone)

Critical: Salacia inhibits postprandial glucose elevation only when carbohydrates require enzymatic breakdown. Animal studies (Shimoda 1998, Yoshikawa 2002) confirmed no effect on glucose-loaded or lactose-loaded rats — confirming the mechanism is enzymatic rather than absorption-blocking.

Clinical trials

1
Williams 2007 — Salacia oblonga in Type 2 Diabetes
PubMed

Acute postprandial trial in T2D patients (Williams, Choe, Noss, Baumgartner, Mustad 2007, Am J Clin Nutr 86(1):124-30).

Patients with type 2 diabetes consuming a meal challenge with or without Salacia oblonga extract.

Salacia oblonga lowered acute postprandial glycemia in patients with type 2 diabetes. Demonstrated that the α-glucosidase inhibitor mechanism translates to clinically relevant reductions in real-world meal contexts in the population most likely to benefit.

2
Heacock 2005 — Salacia oblonga Dose-Response
PubMed

Double-masked, randomized crossover trial (Heacock, Hertzler, Williams, Wolf 2005, J Am Diet Assoc 105(1):65-71).

39 healthy non-diabetic adults (BMI 23.7 ± 0.4, age 25.7 ± 0.9 years). Each subject consumed test meals with 0, 500, 700, or 1000 mg of Salacia oblonga extract on 4 separate occasions.

S. oblonga extract tended to lower postprandial glycemia and significantly reduced postprandial insulin response. Dose-dependent effect on breath hydrogen excretion (8 hours post-meal) confirmed the α-glucosidase inhibitor mechanism analogous to prescription acarbose. Established human dose-response with no GI tolerability issues at any tested dose.

3
Jeykodi 2016 — Salacia chinensis Crossover RCT
PubMed

Randomized double-blind, placebo-controlled crossover study (Jeykodi, Deshpande, Juturu 2016, J Diabetes Res 7971831).

Healthy adult volunteers receiving sucrose challenge with or without Salacia chinensis extract.

Salacia chinensis extract significantly improved postprandial glucose and insulin responses compared with placebo. Authors framed this as the first sucrose-loading study using FDA-recommended methodology for α-glucosidase inhibitors with this species. Results support extension of the Salacia family pharmacology to S. chinensis.

4
Koteshwar 2013 — NR-Salacia Postprandial Hyperglycemia
PubMed

Randomized double-blind, placebo-controlled crossover study (Koteshwar, Raveendra, Allan, Goudar, Venkateshwarlu, Agarwal 2013, Pharmacogn Mag 9(36):344-9).

Healthy volunteers receiving carbohydrate-rich meal with NR-Salacia or placebo.

NR-Salacia (a Salacia reticulata branded extract) significantly lowered postprandial plasma glucose levels after a carbohydrate-rich meal. Authors concluded NR-Salacia can be used as an oral hypoglycemic agent for postprandial glucose management.

5
Stohs 2015 — Salacia reticulata Comprehensive Review
PubMed

Systematic review of antidiabetic and antihyperlipidemic effects and safety (Stohs, Ray 2015, Phytother Res 29(7):986-95).

Aggregated human and animal studies of S. reticulata and related Salacia species.

Authors concluded extensive evidence supports Salacia species reducing postprandial blood glucose, fasting blood glucose, HbA1c, and improving lipid profiles in T2D patients. Safety data show good tolerability with mild GI side effects (gas, soft stools) at higher doses — consistent with carbohydrate fermentation mechanism. Authors flagged need for larger long-term trials.

Side effects and drug interactions

Common Potential side effects

Mild GI symptoms (flatulence, soft stools, abdominal distension) are common and dose-dependent — same as prescription acarbose, reflecting unabsorbed carbohydrates fermenting in the colon. Usually subsides within 1-2 weeks.
Hypoglycemia risk is low in monotherapy because Salacia only blunts post-meal spikes, but combined with insulin or sulfonylureas it could contribute.
Theoretical: long-term effects of altered colonic fermentation are not extensively studied.
Allergic reactions are rare but possible with any plant extract.

Important Drug interactions

Insulin and insulin secretagogues (sulfonylureas, glinides) — Salacia may potentiate glycemic effects; monitor blood glucose, dose adjustment may be needed.
Acarbose and miglitol (prescription α-glucosidase inhibitors) — redundant mechanism; combining could increase GI side effects without proportionate benefit.
Metformin — generally compatible and complementary mechanisms; many trials use Salacia as add-on to metformin without issue.
Drugs requiring intact gut absorption — theoretically slowed if taken with Salacia + carbohydrate meal; separate timing if needed.

More Metabolic Health Ingredients

Cardiovascular
Niacin
Niacin, or vitamin B3, is a vital nutrient that supports energy production by serving as a…
Muscle & Recovery
Magnesium
Magnesium is the fourth most abundant mineral in the body and a cofactor for over 300 enzy…
Cardiovascular
Pycnogenol® (French Maritime Pine Bark)
Pycnogenol® (Horphag Research) is a standardized extract from the bark of French maritime…
Metabolic Health
Psyllium Husk (Plantago ovata)
Psyllium husk is the soluble fiber derived from the seed husks of Plantago ovata — the mos…

Frequently asked questions about Salacia (Salacinol)

What is Salacia (Salacinol)?

Ayurvedic plant genus (Kothala himbutu) with α-glucosidase inhibitor activity.

What does Salacia (Salacinol) do?

Salacinol and kotalanol — unique thiosugar sulfonium sulfate compounds — competitively inhibit intestinal brush border α-glucosidase enzymes (sucrase, maltase, isomaltase). In clinical research, Salacia (Salacinol) has been studied for reduced postprandial glucose spikes, reduced insulin response, hba1c improvement (t2d).

Who should take Salacia (Salacinol)?

Salacia (Salacinol) may be most relevant for people interested in metabolic health, weight management. It has been clinically studied for reduced postprandial glucose spikes, reduced insulin response, hba1c improvement (t2d). As with any supplement, consult your healthcare provider before starting, especially if you have medical conditions or take prescription medications.

How long does Salacia (Salacinol) take to work?

Most clinical trial effects appear over weeks of consistent use; individual response varies. Acute or same-day effects (where applicable) typically appear within hours, but most cumulative benefits — particularly those affecting biomarkers, mood, sleep quality, or chronic symptoms — require 4-12 weeks of regular use to fully assess. If you don't notice benefit after 12 weeks at the appropriate dose, it may not be your responder.

When is the best time to take Salacia (Salacinol)?

For cardiovascular or metabolic goals, Salacia (Salacinol) is typically taken with meals to support absorption and reduce GI sensitivity. Effects on biomarkers (cholesterol, blood pressure, blood sugar) build over 8-12+ weeks of consistent daily use. Always check product labeling and follow personalized guidance from your healthcare provider.

Is Salacia (Salacinol) worth taking?

Salacia (Salacinol) has moderate clinical evidence (Evidence Level 3/5 on NutraSmarts) — meaningful trial support exists, though results are less consistent than top-tier ingredients. Whether it's worth taking depends on your specific goals, what you've already tried, your budget, and your overall supplement strategy. The honest framing: no supplement is essential for most people, and lifestyle factors (sleep, exercise, diet, stress management) typically produce larger effects than any single supplement. Salacia (Salacinol) is most worth trying if its evidence-supported uses align with your specific goals.

What is the recommended dosage of Salacia (Salacinol)?

The clinically studied dose for Salacia (Salacinol) is T2D (Kajimoto): 240 mg/day S. reticulata × 6 wk. NR-Salacia: 250-500 mg with carb meal. Heacock 2005: 500-1000 mg S. oblonga. STANDARD: 200-1000 mg with largest carb meal.. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is Salacia (Salacinol) used for?

Salacia (Salacinol) is studied for reduced postprandial glucose spikes, reduced insulin response, hba1c improvement (t2d). Multiple human RCTs across S. reticulata, S. oblonga, and S. chinensis consistently show 14-29% reductions in postprandial glucose AUC after carbohydrate-rich meals when Salacia is co-administered.